The effects of vitamin E-coated dialysis membranes on serum paraoxonase activity in hemodialysis patients

Journal of Nephrology

Volumn 23, Issue 4, 2010, Pages 431-437

  Sarandol, Emre ^a   Dirican, Melahat ^a   Ocak, Nihal ^a   Serdar, Zehra ^a   Sonmezisik, Faruk ^a   Dilek, Kamil ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Hemodialysis; Oxidative stress; Paraoxonase; Vitamin E coated dialysis membrane

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN B CONTAINING LIPOPROTEIN; ARYLDIALKYLPHOSPHATASE; ASCORBIC ACID; CAROTENOID; LIPOPROTEIN; MALONALDEHYDE; UNCLASSIFIED DRUG; ARTIFICIAL MEMBRANE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TOCOPHEROL;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE OXIDIZABILITY; ERYTHROCYTE PARAMETERS; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMMUNITY; KIDNEY FAILURE; LIPID PEROXIDATION; MALE; MATERIAL COATING; OXIDATIVE STRESS; VITAMIN BLOOD LEVEL; ADOLESCENT; ARTIFICIAL MEMBRANE; BLOOD; ERYTHROCYTE; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADOLESCENT; ADULT; AGED; ARYLDIALKYLPHOSPHATASE; ERYTHROCYTES; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; RENAL DIALYSIS; TOCOPHEROLS;

EID: 77955445113     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62:1524-1538.
2. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18:1272-1280. (Pubitemid 36826946)
3. Mackness MI, Arrol S, Abbott CA, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high density lipoprotein associated paraoxonase. Atherosclerosis. 1993;104:129-135.
4. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo- Parmo SL, La Du BN. Paraoxonase inhibits high density lipoprotein (HDL) oxidation and preserves its functions: a possible peroxidative role for paraoxonase. J Clin Invest. 1998;101:1581-1590.
5. Aviram M, Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med. 2004 1;37:1304-1316.
6. Dirican M, Akça R, Sarandöl E, Dilek K. Serum paraoxonase activity in uremic predialysis and hemodialysis patients. J Nephrol. 2004;17:813-818. (Pubitemid 41158301)
7. Dirican M, Sarandöl E, Serdar Z, Ocak N, Dilek K. Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure trated by hemodialysis. Clin Nephrol. 2007;68:144-150.
8. Ersoy A, Şenol E, Erdinç S, Sarandöl E, Yurtkuran M. Oxidative Stress and Ferritin Levels in Hemodialysis Patients. Nephrol Dial Transplant. 2008;23:665-672.
9. Ikeda Y, Suehiro T, Itahara T, et al. Human serum paraoxonase concentration predicts cardiovascular mortality in hemodialysis patients. Clin Nephrol. 2007;67:358-365.
10. Jurek A, Turyna B, Kubit P, Klein A. LDL susceptibility to oxidation and HDL antioxidant capacity in patients with renal failure. Clin Biochem. 2006;39:19-27. (Pubitemid 43005266)
11. Ferretti G, Bacchetti T, Masciangelo S, Pallotta G. Lipid per- oxidation in hemodialysis patients: effect of vitamin C supplementation. Clin Biochem. 2008;41:381-386.
12. Morena M, Martin-Mateo M, Cristol JP, Canaud B. Rationale for antioxidant supplementation in hemodialysis patients. Saudi J Kidney Dis Transpl. 2001;12:312-324. (Pubitemid 33326830)
13. Cruz DN, de Cal M, Ronco C. Oxidative stress and anemia in chronic hemodialysis: the promise of bioreactive membranes. Contrib Nephrol. 2008;161:89-98.
14. Sosa MA, Balk EM, Lau J, et al. A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation. Nephrol Dial Transplant. 2006;21:2825-2833. (Pubitemid 44542238)
15. Young IS, Trimble ER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem. 1991;28:504-508.
16. Zhang A, Vertommen J, Van Gaal L, De Leeuw I. A rapid and simple method for measuring the susceptibility of low-density lipoprotein and very-low-density lipoprotein to copper-catalyzed oxidation. Clin Chim Acta. 1993;227:159-173.
17. Mosca L, Rubenfire M, Tarshis T, Tsai A, Pearson T. Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease. Am J Cardiol. 1997;80:825-830. (Pubitemid 27459152)
18. Buege JA, Aust SD. Microsomal lipid peroxidation. In: Fleicher S, Packer L, eds. Methods in Enzymology. London: Academic Press; 1978:302-309.
19. Stocks J, Offerman EL, Modell CB, Dormandy TL. The susceptibility to autoxidation of human red cell lipids in health and disease. Br J Haematol. 1972;23:713-724.
20. Fairbanks V, Klee GG. Biochemical aspects of haematology. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. Philadelphia: WB Saunders; 1994:2020-2021.
21. Eckerson HW, Wyte MC, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet. 1983;35:1126-1138.
22. McCormick DB, Greene HL. Vitamins. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. Philadelphia: WB Saunders; 1994:1313-1314.
23. Neeld JB, Pearson WN. Macro- and micro-methods for the determination of serum vitamin A using trifluoroacetic acid. J Nutr. 1963;79:454-462.
24. Teissier E, Walters-Laport E, Duhem C, Luc G, Fruchart JC, Duriez P. Rapid quantification of α tocopherol in plasma and low- and high-density lipoproteins. Clin Chem. 1996;42:430-435.
25. Aviram M, Rosenblat M, Billecke S, et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med. 1999;26:892-904. (Pubitemid 29198362)
26. Mydlík M, Derzsiová K, Rácz O, Sipulová A, Lovásová E. Antioxidant therapy by oral vitamin E and vitamin E-coated dialyzer in CAPD and haemodialysis patients. Prague Med Rep. 2006;107:354-364.
27. Triolo L, Malaguti M, Ansali F, et al. Vitamin E-bonded cellulose membrane, lipoperoxidation, and anemia in hemodialysis patients. Artif Cells Blood Substit Immobil Biotechnol. 2003;31:185-191.
28. Eiselt J, Racek J, Trefil L, Opatrný K Jr. Effects of a vitamin E-modified dialysis membrane and vitamin C infusion on oxidative stress in hemodialysis patients. Artif Organs. 2001;25:430-436.
29. Bonnefont-Rousselot D, Lehmann E, Jaudon MC, Delattre J, Perrone B, Rechke JP. Blood oxidative stress and lipoprotein oxidizability in haemodialysis patients: effect of the use of a vitamin E-coated dialysis membrane. Nephrol Dial Transplant. 2000;15:2020-2028.
30. Mune M, Yukawa S, Kishino M, et al. Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients. Kidney Int Suppl. 1999;71:126-129.
31. Yang CC, Hsu SP, Wu MS, Hsu SM, Chie CT. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis- induced oxidative stress. Kidney Int. 2006;69:706-714.
32. Tarng DC, Huang TP, Liu TY, Chen HW, Sung YJ, Wei YH. Effect of vitamin E-bonded membrane on the 8-hydroxy 2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int. 2000;58:790-799.
33. Bufano G, Usberti M, Mandolfo S, Malberti F, Piroddi M, Galli F. Von Willebrand factor and autoantibodies against oxidized LDL in hemodialysis patients treated with vitamin E-modified dialyzers. Int J Artif Organs. 2004;27:214-221.
34. Gugliucci A, Menini T, Stahl AJ. Susceptibility to copper- enhanced autoxidation of VLDL+LDL fractions from diabetic patients. Biochem Mol Biol Int. 1994;32:139-147. (Pubitemid 24077252)
35. Morimoto H, Nakao K, Fukuoka K, et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant. 2005;20:2775-2782. (Pubitemid 41672279)
36. Shimazu T, Ominato M, Toyama K, et al. Effects of a vitamin E-modified dialysis membrane on neutrophil superoxide anion radical production. Kidney Int. 2001;59:137-143.
37. Tsuruoka S, Kawaguchi A, Nishiki K, et al. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure. Am J Kidney Dis. 2002;39:127-133. (Pubitemid 34062505)
38. Buoncristiani U, Galli F, Rovidati S, Albertini MC, Campus G, Canestrari F. Oxidative damage during hemodialysis using a vitamin E-modified dialysis membrane: A preliminary characterization. Nephron. 1997;77:57-61. (Pubitemid 27395342)